Podcast Episode

Inside CAR T‑Cell Therapy: How Innovation Is Changing Lives

CAR T‑cell therapy is redefining what personalized cancer treatment can look like, offering real promise for patients and families.

In this episode, we speak with Dr. Richard Maziarz and CAR T Nurse Coordinator Bashi Ratterree of Oregon Health & Science University (OHSU). Together, they explain how CAR T‑cell therapy works, who may be eligible, what patients can expect during treatment and recovery, and the promising advancements shaping the future of this innovative therapy.

CLICK HERE to participate in our episode survey.

Mentioned on this episode: 

Additional Blood Cancer United Support Resources: 

Episode supported by Bristol Myers Squibb; Johnson & Johnson & Legend Biotech;  Kite, a Gilead Company; Novartis Pharmaceuticals Corporation.

4 thoughts on “Inside CAR T‑Cell Therapy: How Innovation Is Changing Lives”

    1. Hello Gary,

      MDS, or myelodysplastic syndromes is a myeloid cancer like CML and AML that we discussed in the episode. There are currently clinical trials for CAR T-cell therapy for MDS. If you’d like to learn if you are qualified for a clinical trial, we would encourage you to contact our Clinical Trial Support Center at http://www.BloodCancerUnited.org/CTSC.

      You can also see more about CAR T-cell therapy for MDS at https://www.youtube.com/watch?v=SS1EvAP_120

  1. Thanks for sharing this encouraging podcast. I was diagnosed with lymphoma six years ago, had five years of cancer free follow ups and in this 6th year am waiting to hear from my oncologist on a biopsy and PET scan. I will be learning what is next next this week and plan on bringing up the CAR t-Cell therapy.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top